About

Mr. Harrison has served as a director of Acurx since July 2021. Since June 2016 he has been Chairman Emeritus of the Diversified Agency Services (DAS) division of Omnicom Group Inc. (NYSE: OMC), having previously served as its President and then Chairman and Chief Executive Officer; under his leadership DAS grew into Omnicom's largest division with annual revenues over $6.0 billion. He joined Omnicom in 1992 when it acquired Harrison & Star Business Group, the healthcare agency he co-founded, and in 2019 became a Senior Operating Partner at Merida Capital Partners. Mr. Harrison began his career at Pfizer Laboratories as a pharmaceutical sales representative. He earned an L.H.D. and M.S. in cell biology from West Virginia University and a B.S. in cell biology and physiology from Shepherdstown University.

Roles

Acurx Pharmaceuticals, Inc.
Director · Current role
July 2021–present
Omnicom Group Inc. - Diversified Agency Services (DAS)
Chairman Emeritus
2016 - present
Omnicom Group Inc. - Diversified Agency Services (DAS)
Chairman & Chief Executive Officer
1998 - 2013
Merida Capital Partners
Senior Operating Partner
2019 - present
Harrison & Star Business Group
Co-Founder & Chairman
—

External Roles

Madison Logic
Director
2017 - present
New Frontier Data
Director
2022 - present
ACTV8me
Director
2019 - present
MainStem
Director
—
Zynerba Pharmaceuticals
Director
2015 - 2019
Dipexium Pharmaceuticals, Inc.
Director
2011 - 2017

Director Compensation

FY 2024
Fees earned or paid in cash
$52,500
ComponentAnnual cash retainers and committee/leadership fees earned in 2024
Option awards
$22,104
ComponentStock options granted during 2024, ASC 718 grant-date fair value
Total
$74,604

Also at Acurx Pharmaceuticals, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.